Johnson & Johnson

JNJ

Current ValuationThe current P/E ratio is 39.81, above the reasonable range, cheaper than 0.54% of the time in the past 5 years, and the industry ranks 46/257, the industry Median -1.07.

39.81xP/E
Stock price$266.17Earnings per share$6.69

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
03774111148

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
JNJUSJohnson & Johnson
39.81x38.06%$640.75B
PFEUSPfizer
39.45x22.19%$170.99B
RDYUSDr Reddys Laboratories
39.84x12.08%$11.91B
AMRXUSAmneal Pharmaceuticals
41.01x122.71%$6.45B
IBOUSImpact BioMedical
43.42x--$34.35M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.